Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exiqon
Vedbaek, Denmarkexiqon.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Exiqon was a leading provider of high-performance solutions for RNA analysis, specializing in the development and commercialization of Locked Nucleic Acid (LNA) technology. The company's products included tools for microRNA (miRNA) discovery, profiling, and functional analysis, as well as diagnostic tests for personalized medicine. By leveraging the high affinity and specificity of LNA, Exiqon enabled researchers to achieve superior results in RNA detection and quantification. The company offered a comprehensive portfolio of miRCURY LNA products, including PCR assays, arrays, and in situ hybridization probes. In 2016, Exiqon was acquired by QIAGEN, which integrated its LNA-based portfolio into its molecular diagnostics and life science offerings.
- Therapeutic areas
- OncologyCardiovascularNeurology
- Modalities
- Synthetic oligonucleotideLocked Nucleic Acid
- Industry
- Molecular Diagnostics
02
Partnerships
OncomineMDRNASantaris Pharma
Beyond the preview
Go deeper on Exiqon.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Exiqon.